EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

CONMED Corporation (CNMD) had EBITDA of $58.12M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$342.35M
Net Income	$21.42M
Cost of Goods Sold	$154.03M
Gross Profit	$188.32M
Operating Expenses	$304.18M
Operating Income	$38.16M
Non-Operating Income/Expense	$-8.24M
Pre-Tax Income	$29.92M
Normalized Pre-Tax Income	$29.92M
Income after Taxes	$21.42M
Income from Continuous Operations	$21.42M
Consolidated Net Income/Loss	$21.42M
Normalized Income after Taxes	$21.42M
EBIT	$38.16M
EBITDA	$58.12M
Weighted-Average Shares Outstanding (Basic)	30.95M
Weighted-Average Shares Outstanding (Diluted)	31.05M
Earnings per Share (EPS) (Basic)	$0.69
Earnings per Share (EPS) (Diluted)	$0.69
Balance Sheet Financials
Current Assets	$657.78M
Property, Plant, and Equipment	$116.86M
Long-Term Assets	$1.67B
Total Assets	$2.33B
Current Liabilities	$294.84M
Long-Term Debt	$881.11M
Long-Term Liabilities	$1.03B
Total Liabilities	$1.33B
Common Equity	$1.00B
Tangible Shareholders Equity	$-405.87M
Shareholders Equity	$1.00B
Common Shares Outstanding	30.95M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$70.67M
Cash Flow from Investing Activities	$-8.66M
Cash Flow from Financial Activities	$-54.92M
Beginning Cash	$24.46M
End Cash	$33.94M
Increase/Decrease in Cash	$9.48M
Stock-Based Compensation	$18.77M
Common Stock Dividends Paid	$-12.37M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.23
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.47
Debt to Equity Ratio	0.88
Gross Margin	55.01%
Operating Margin	11.15%
EBIT Margin	11.15%
EBITDA Margin	--
Pre-Tax Profit Margin	8.74%
Profit Margin	6.26%
Free Cash Flow	$61.16M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	0.43
Receiveable Turnover	1.46
Days Sales in Receivables	61.56
Return on Equity	2.14%
Return on Tangible Equity	-5.28%
Return on Assets	0.92%
Return on Investments	1.14%
Book Value Per Share	$32.41
Free Cash Flow per Share	$1.97
Operating Cash Flow per Share	$2.28

Data from Zacks Investment Research, Inc.